scholarly journals Progress and Perspectives on HIV-1 microbicide development

Virology ◽  
2016 ◽  
Vol 497 ◽  
pp. 69-80 ◽  
Author(s):  
Kabamba B. Alexandre ◽  
Hazel T. Mufhandu ◽  
Grace M. London ◽  
E. Chakauya ◽  
M. Khati
2007 ◽  
Vol 5 (1) ◽  
pp. 28 ◽  
Author(s):  
Hela Saïdi ◽  
Nadine Nasreddine ◽  
Mohammad-Ali Jenabian ◽  
Maxime Lecerf ◽  
Dominique Schols ◽  
...  

PLoS ONE ◽  
2011 ◽  
Vol 6 (9) ◽  
pp. e24803 ◽  
Author(s):  
Xudong Lin ◽  
Elena E. Paskaleva ◽  
William Chang ◽  
Alexander Shekhtman ◽  
Mario Canki

2014 ◽  
Vol 58 (10) ◽  
pp. 6215-6223 ◽  
Author(s):  
Massimiliano Secchi ◽  
Lia Vassena ◽  
Sébastien Morin ◽  
Dominique Schols ◽  
Luca Vangelista

ABSTRACTR4.0, a synthetic CCL5/RANTES-derived peptide, exerts potent anti-HIV-1 activity via its nonactivating interaction with CCR5, the major HIV-1 coreceptor. CCR5 chronic activation may promote undesirable inflammatory effects and enhance viral infection; thus, receptor antagonism is a necessary requisite. HIV-1 gp120, CCL5, and maraviroc dock on CCR5 by sharing two receptor sites: the N terminus and the second extracellular loop. In combination studies, R4.0, CCL5, and maraviroc exhibited concomitant interactions with CCR5 and promoted synergic inhibition of HIV-1 in acute-infection assays. Furthermore, various degrees of additive/synergic HIV-1 inhibition were observed when R4.0 was tested in combination with drugs and lead compounds directed toward different viral targets (gp120, gp41, reverse transcriptase, and protease). In combination with tenofovir, R4.0 provides cross-clade synergic inhibition of primary HIV-1 isolates. Remarkably, anin vitro-generated maraviroc-resistant R5 HIV-1 strain was inhibited by R4.0 comparably to the wild-type strain, suggesting the presence of viral resistance barriers similar to those reported for CCL5. Overall, R4.0 appears to be a promising lead peptide with potential for combination in anti-HIV-1 therapy and in microbicide development to prevent sexual HIV-1 transmission.


Author(s):  
James K. Koehler ◽  
Steven G. Reed ◽  
Joao S. Silva

As part of a larger study involving the co-infection of human monocyte cultures with HIV and protozoan parasites, electron microscopic observations were made on the course of HIV replication and infection in these cells. Although several ultrastructural studies of the cytopathology associated with HIV infection have appeared, few studies have shown the details of virus production in “normal,” human monocytes/macrophages, one of the natural targets of the virus, and suspected of being a locus of quiescent virus during its long latent period. In this report, we detail some of the interactions of developing virons with the membranes and organelles of the monocyte host.Peripheral blood monocytes were prepared from buffy coats (Portland Red Cross) by Percoll gradient centrifugation, followed by adherence to cover slips. 90-95% pure monocytes were cultured in RPMI with 5% non-activated human AB serum for four days and infected with 100 TCID50/ml of HIV-1 for four hours, washed and incubated in fresh medium for 14 days.


1997 ◽  
Vol 23 (3) ◽  
pp. 83-92 ◽  
Author(s):  
D. Seilhean ◽  
A. Dzia-Lepfoundzou ◽  
V. Sazdovitch ◽  
B. Cannella ◽  
C. S. Raine ◽  
...  

2000 ◽  
Vol 14 (2) ◽  
pp. 50-55
Author(s):  
FORTHEPEDIATRICPULMONARYANDCA ◽  
H COHEN ◽  
X CHEN ◽  
S SUNKLE ◽  
L DAVIS ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document